immunity News and Research

RSS

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Researchers have developed EVScape, a predictive tool that identifies which SARS-CoV-2 strains are most likely to evade host immunity. Utilizing a deep generative model and structural information, the tool offers early warning about viral variants, aiding in the timely development of effective vaccines and treatments.

12 Oct 2023

Is there an association between vitamin D deficiency and sepsis mortality?

The impact of deficient serum vitamin D levels on sepsis prognosis.

12 Oct 2023

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.

12 Oct 2023

Could young blood be the key to reversing age-related cognitive decline?

Researchers at the University of Auckland identify platelet factor 4 (PF4) in young blood as a key player in reversing age-related cognitive decline in mice. The study offers a promising avenue for treating dementia-related conditions and enhancing brain function in aging populations.

11 Oct 2023

CT scan of the thymus reveals immune system aging

Thymus, a small and relatively unknown organ, may play a bigger role in the immune system of adults than was previously believed.

11 Oct 2023

New nanocapsule treatment boosts immune response against solid tumors

UCLA researchers have developed a new treatment method using a tiny nanocapsule to help boost the immune response, making it easier for the immune system to fight and kill solid tumors.

11 Oct 2023

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

The intricate interactions between gut microbiota and drugs.

11 Oct 2023

New TB vaccination strategy could save hundreds of thousands of lives with HIV

Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.

10 Oct 2023

COVID-19 vaccine response lower in patients with lung conditions, study finds

Clinicians and researchers at National Jewish Health studied COVID vaccine effectiveness in patients with underlying lung conditions such as asthma, chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).

10 Oct 2023

Protein antigen from a childhood vaccine can help refocus the body's immune system against cancer

A University of Massachusetts Amherst team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body's immune system against the cancer, effectively halting it and preventing its recurrence.

10 Oct 2023

Gut defenders: How T-cell intraepithelial lymphocytes guard against colon cancer

In the latest research published in Science Immunology, experts delve into the gene expression patterns of distinct intraepithelial lymphocyte populations in various gastrointestinal tract regions. Key findings reveal the roles of T-cell IELs in detecting infections and ensuring the gut's barrier integrity, with a special emphasis on their function in combating colon cancer.

9 Oct 2023

Breast milk microbiome changes after COVID-19 vaccination, linked to enhanced infant protection

Study explored the association between BNT162b2 vaccine-induced antibodies and the breast milk microbiome in 49 breastfeeding mothers, revealing that post-vaccination alterations in the microbiome were linked to humoral protection against SARS-CoV-2.

9 Oct 2023

Immature immune cells near dural sinuses linked to neonatal viral meningoencephalitis

Examine virus propagation within central nervous systems (CNSs) during systemic infection.

9 Oct 2023

Next-gen intranasal vaccine takes on measles, mumps, and multiple COVID-19 variants in one shot

Researchers developed an intranasal trivalent measles-mumps-SARS-CoV-2 vaccine that provides robust protection against multiple coronavirus variants. Leveraging the established measles-mumps-rubella platform, this vaccine demonstrates broad and adaptable immune responses, especially against Delta and Omicron variants.

8 Oct 2023

Novavax vaccine shows resilient defense against symptomatic COVID-19 despite Omicron challenge

Recent study assesses NVX-CoV2373 vaccine's effectiveness against Omicron variant. Findings show decreased efficacy over four months, but stable protection against symptomatic COVID-19.

8 Oct 2023

Protein recombinant vaccine NVX-CoV2373 confers protection during Omicron dominant period in Italy

The NVX-CoV2373 COVID-19 vaccine offers significant protection against symptomatic infections, but its effectiveness against SARS-CoV-2 declines within four months, according to a study in JAMA Network Open using Italian data. However, its protection against symptomatic COVID-19 seems to remain stable during this period.

8 Oct 2023

Breakthrough research could lead to more effective immunotherapies for bowel cancer

Every year, over 15,500 Australians are diagnosed with bowel cancer, and it is the second leading cause of cancer deaths in the country.

6 Oct 2023

People may experience 'long colds' after acute respiratory infections, study finds

A new study from Queen Mary University of London, published in The Lancet's EClinicalMedicine, has found that people may experience long-term symptoms -;or 'long colds'-;after acute respiratory infections that test negative for COVID-19.

6 Oct 2023

Differences in immune responses to SARS-CoV-2 variants could inform future vaccine design

A person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure - and differences in the focus of immune responses will help scientists understand how to optimize vaccines in the future to provide broad protection.

6 Oct 2023

Pre-existing CMV immunity protects mothers and babies from transmission and birth defects

Researchers at Tulane University have shown for the first time that mothers are much less likely to transmit a common virus known to cause miscarriages and birth defects if they are exposed to the virus prior to becoming pregnant.

6 Oct 2023

immunity News and Research

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Is there an association between vitamin D deficiency and sepsis mortality?

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

Could young blood be the key to reversing age-related cognitive decline?

CT scan of the thymus reveals immune system aging

New nanocapsule treatment boosts immune response against solid tumors

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

New TB vaccination strategy could save hundreds of thousands of lives with HIV

COVID-19 vaccine response lower in patients with lung conditions, study finds

Protein antigen from a childhood vaccine can help refocus the body's immune system against cancer

Gut defenders: How T-cell intraepithelial lymphocytes guard against colon cancer

Breast milk microbiome changes after COVID-19 vaccination, linked to enhanced infant protection

Immature immune cells near dural sinuses linked to neonatal viral meningoencephalitis

Next-gen intranasal vaccine takes on measles, mumps, and multiple COVID-19 variants in one shot

Novavax vaccine shows resilient defense against symptomatic COVID-19 despite Omicron challenge

Protein recombinant vaccine NVX-CoV2373 confers protection during Omicron dominant period in Italy

Breakthrough research could lead to more effective immunotherapies for bowel cancer

People may experience 'long colds' after acute respiratory infections, study finds

Differences in immune responses to SARS-CoV-2 variants could inform future vaccine design

Pre-existing CMV immunity protects mothers and babies from transmission and birth defects

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News